ClinicalTrials.gov
public full text
Public Domain
GRN1005 in Non-Small Cell Lung Cancer (NSCLC) Patients With Brain Metastases (GRABM-L)
The purpose of this study is to assess the efficacy, safety, and tolerability of GRN1005 in patients with brain metastases from non-small cell lung cancer (NSCLC).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Efficacy of Gefitinib for Brain Metastasis of Non-Small Cell Lung Cancer#910290
- ZK219477 (Sagopilone) in Patients With Breast Cancer and Brain Metastases#888550
- Safety and Efficacy Study of Icotinb in Non-small Cell Lung Cancer (NSCLC) Patients#886284
- Supplemental Material for: Case Report: Dose dependent intracranial response to sotorasib in KRASG12C-mutated lung cancer brain metastases#482274
- A Study of the Gene Mutation Status in Cerebrospinal Fluid, Blood and Tumor Tissue of Non-small Cell Lung Cancer Patients With Brain Metastases#854201
Record · ID 1114122
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive